SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavaxs sharp rally is being linked by traders to reports of a suspected plague outbreak in Russia and renewed vaccine-stock interest, though the connection remains speculative. Much of the discussion centers on a possible short squeeze as shares approach a 52-week high, while some traders caution that the move may be FOMO without a confirmed company catalyst.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs sharp rally and breakout are drawing attention, with bulls citing Morgan Stanleys favorable valuation view and optimism around AI-compute growth; traders also point to TSMCTerafab speculation and the proposed SpaceXSI rebrand. Skeptics argue the valuation is stretched and warn that upcoming share unlocks could add selling pressure.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

GRRR is under pressure amid broader AI-sector weakness, with traders also focused on unresolved financing for its large AI data-center projects and the risk of dilution from convertible debt. Bulls point to contracts and Yotta deployments as growth potential, while skeptics want documented financing, customer acceptance, and revenue execution before trusting managements projections.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Jobys Texas eIPP flights, autonomous cross-country flight, and progress toward final FAA certification are fueling discussion about its path to commercial operations. Bulls see these milestones as evidence of execution, while bears focus on persistent share-price weakness, cash burn, potential dilution, and insider selling; some traders also cite a reported court verdict as an added financial risk.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulfs plan to double contracted power capacity at its Muskie campus to 1 GW is drawing attention, with traders debating why the shares fell despite the expansion news. Bulls view the added capacity as support for its AI/HPC growth strategy, while bears point to financing and buildout costs, dilution risk, and delayed revenue; broader weakness across data-center stocks is also cited.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas sharp rerating is tied mainly to positive Phase 3 results for its Merck-partnered melanoma vaccine, with Nasdaq-100 inclusion adding attention. Traders remain divided: bulls cite the cancer pipeline and possible short covering, while bears argue the rally has outrun the evidence and point to Citis Sell downgrade and valuation concerns.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidias push to fresh highs is fueling bullish momentum, with traders pointing to continued AI and data-center demand; Foxconns strong sales offered a supporting demand signal. Others question the rallys staying power, citing valuation, rising bond yields, AI spending risks and choppy price action.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors 24-month HOPE-3 extension data showing slower upper-limb decline in Duchenne muscular dystrophy have renewed focus on deramiocel, but the shares are under pressure as traders weigh the encouraging results against FDA concerns about the trials statistical analysis and the November decision. Views are divided on whether the added data support approval or whether the FDA may issue another rejection.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Optical-connectivity shares are drawing interest on sympathy with Cornings Verizon fiber deal, reinforcing the communitys broader AI data-center and photonics demand thesis. Traders are bullish on the sector move but remain divided on AAOI, with recurring concerns that ATM share sales and volatility could weigh on its gains.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Russia-related plague headlines are fueling interest in Emergents biodefense business, alongside speculation about a short squeeze and potential government contract awards. Traders are also debating a possible buyout, but anticipated awards and a squeeze remain unconfirmed.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CLSK insiders and hedgies are buying, so I’m buying 🤣🤷‍♂️

svw007

Landis Frederick

Jerome

StockTwits for iOS

Cleanspark Inc

 insiders and hedgies are buying, so I’m buying 🤣🤷‍♂️

Namis

@Namis Insider Buying vs. Insider Selling 
In the past three months, Cleanspark insiders have sold more of their company&#39;s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $435,473.00 in company stock.

StockTwits Web

 Insider Buying vs. Insider Selling 
In the past three months, Cleanspark insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $435,473.00 in company stock.